Financhill
Buy
52

SOLV Quote, Financials, Valuation and Earnings

Last price:
$72.95
Seasonality move :
-3.45%
Day range:
$72.17 - $73.59
52-week range:
$60.70 - $88.20
Dividend yield:
0%
P/E ratio:
8.40x
P/S ratio:
1.52x
P/B ratio:
2.54x
Volume:
1.1M
Avg. volume:
1M
1-year change:
-2.09%
Market cap:
$12.7B
Revenue:
$8.3B
EPS (TTM):
$8.69

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SOLV
Solventum Corp.
$2B $1.50 -5.67% 87.42% $89.25
ALGN
Align Technology, Inc.
$1B $2.97 4.3% 78.2% $198.57
MLSS
Milestone Scientific, Inc.
$2.3M -$0.02 14.7% -42.53% $1.00
SONX
Sonendo
-- -- -- -- --
XRAY
Dentsply Sirona, Inc.
$926.4M $0.29 1.65% 250.92% $13.23
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SOLV
Solventum Corp.
$72.94 $89.25 $12.7B 8.40x $0.00 0% 1.52x
ALGN
Align Technology, Inc.
$190.02 $198.57 $13.6B 33.58x $0.00 0% 3.42x
MLSS
Milestone Scientific, Inc.
$0.26 $1.00 $20.3M -- $0.00 0% 2.34x
SONX
Sonendo
-- -- -- -- $0.00 0% --
XRAY
Dentsply Sirona, Inc.
$12.54 $13.23 $2.5B -- $0.16 5.1% 0.69x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SOLV
Solventum Corp.
50.75% 0.723 40.57% 0.94x
ALGN
Align Technology, Inc.
2% 1.016 0.74% 1.14x
MLSS
Milestone Scientific, Inc.
29.24% -0.601 2.95% 0.69x
SONX
Sonendo
-- 0.000 -- --
XRAY
Dentsply Sirona, Inc.
62.66% 1.554 97.97% 0.73x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SOLV
Solventum Corp.
$1.1B $171M 13.6% 42.2% 8.16% -$21M
ALGN
Align Technology, Inc.
$688.1M $159.6M 10.19% 10.49% 15.24% $223.2M
MLSS
Milestone Scientific, Inc.
$1.6M -$1.1M -125.67% -142.42% -48.07% $75.6K
SONX
Sonendo
-- -- -- -- -- --
XRAY
Dentsply Sirona, Inc.
$441M $49M -20.14% -44.58% 5.42% $40M

Solventum Corp. vs. Competitors

  • Which has Higher Returns SOLV or ALGN?

    Align Technology, Inc. has a net margin of 60.4% compared to Solventum Corp.'s net margin of 12.96%. Solventum Corp.'s return on equity of 42.2% beat Align Technology, Inc.'s return on equity of 10.49%.

    Company Gross Margin Earnings Per Share Invested Capital
    SOLV
    Solventum Corp.
    53.91% $7.22 $10.1B
    ALGN
    Align Technology, Inc.
    65.69% $1.89 $4.1B
  • What do Analysts Say About SOLV or ALGN?

    Solventum Corp. has a consensus price target of $89.25, signalling upside risk potential of 22.36%. On the other hand Align Technology, Inc. has an analysts' consensus of $198.57 which suggests that it could grow by 4.55%. Given that Solventum Corp. has higher upside potential than Align Technology, Inc., analysts believe Solventum Corp. is more attractive than Align Technology, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SOLV
    Solventum Corp.
    5 6 1
    ALGN
    Align Technology, Inc.
    7 8 0
  • Is SOLV or ALGN More Risky?

    Solventum Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Align Technology, Inc. has a beta of 1.841, suggesting its more volatile than the S&P 500 by 84.113%.

  • Which is a Better Dividend Stock SOLV or ALGN?

    Solventum Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solventum Corp. pays -- of its earnings as a dividend. Align Technology, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SOLV or ALGN?

    Solventum Corp. quarterly revenues are $2.1B, which are larger than Align Technology, Inc. quarterly revenues of $1B. Solventum Corp.'s net income of $1.3B is higher than Align Technology, Inc.'s net income of $135.8M. Notably, Solventum Corp.'s price-to-earnings ratio is 8.40x while Align Technology, Inc.'s PE ratio is 33.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solventum Corp. is 1.52x versus 3.42x for Align Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SOLV
    Solventum Corp.
    1.52x 8.40x $2.1B $1.3B
    ALGN
    Align Technology, Inc.
    3.42x 33.58x $1B $135.8M
  • Which has Higher Returns SOLV or MLSS?

    Milestone Scientific, Inc. has a net margin of 60.4% compared to Solventum Corp.'s net margin of -48.9%. Solventum Corp.'s return on equity of 42.2% beat Milestone Scientific, Inc.'s return on equity of -142.42%.

    Company Gross Margin Earnings Per Share Invested Capital
    SOLV
    Solventum Corp.
    53.91% $7.22 $10.1B
    MLSS
    Milestone Scientific, Inc.
    68.68% -$0.01 $3.6M
  • What do Analysts Say About SOLV or MLSS?

    Solventum Corp. has a consensus price target of $89.25, signalling upside risk potential of 22.36%. On the other hand Milestone Scientific, Inc. has an analysts' consensus of $1.00 which suggests that it could grow by 288.2%. Given that Milestone Scientific, Inc. has higher upside potential than Solventum Corp., analysts believe Milestone Scientific, Inc. is more attractive than Solventum Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    SOLV
    Solventum Corp.
    5 6 1
    MLSS
    Milestone Scientific, Inc.
    1 0 0
  • Is SOLV or MLSS More Risky?

    Solventum Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Milestone Scientific, Inc. has a beta of 0.966, suggesting its less volatile than the S&P 500 by 3.437%.

  • Which is a Better Dividend Stock SOLV or MLSS?

    Solventum Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solventum Corp. pays -- of its earnings as a dividend. Milestone Scientific, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SOLV or MLSS?

    Solventum Corp. quarterly revenues are $2.1B, which are larger than Milestone Scientific, Inc. quarterly revenues of $2.4M. Solventum Corp.'s net income of $1.3B is higher than Milestone Scientific, Inc.'s net income of -$1.2M. Notably, Solventum Corp.'s price-to-earnings ratio is 8.40x while Milestone Scientific, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solventum Corp. is 1.52x versus 2.34x for Milestone Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SOLV
    Solventum Corp.
    1.52x 8.40x $2.1B $1.3B
    MLSS
    Milestone Scientific, Inc.
    2.34x -- $2.4M -$1.2M
  • Which has Higher Returns SOLV or SONX?

    Sonendo has a net margin of 60.4% compared to Solventum Corp.'s net margin of --. Solventum Corp.'s return on equity of 42.2% beat Sonendo's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SOLV
    Solventum Corp.
    53.91% $7.22 $10.1B
    SONX
    Sonendo
    -- -- --
  • What do Analysts Say About SOLV or SONX?

    Solventum Corp. has a consensus price target of $89.25, signalling upside risk potential of 22.36%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Solventum Corp. has higher upside potential than Sonendo, analysts believe Solventum Corp. is more attractive than Sonendo.

    Company Buy Ratings Hold Ratings Sell Ratings
    SOLV
    Solventum Corp.
    5 6 1
    SONX
    Sonendo
    0 0 0
  • Is SOLV or SONX More Risky?

    Solventum Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SOLV or SONX?

    Solventum Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Solventum Corp. pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SOLV or SONX?

    Solventum Corp. quarterly revenues are $2.1B, which are larger than Sonendo quarterly revenues of --. Solventum Corp.'s net income of $1.3B is higher than Sonendo's net income of --. Notably, Solventum Corp.'s price-to-earnings ratio is 8.40x while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solventum Corp. is 1.52x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SOLV
    Solventum Corp.
    1.52x 8.40x $2.1B $1.3B
    SONX
    Sonendo
    -- -- -- --
  • Which has Higher Returns SOLV or XRAY?

    Dentsply Sirona, Inc. has a net margin of 60.4% compared to Solventum Corp.'s net margin of -47.35%. Solventum Corp.'s return on equity of 42.2% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    SOLV
    Solventum Corp.
    53.91% $7.22 $10.1B
    XRAY
    Dentsply Sirona, Inc.
    48.78% -$2.14 $4B
  • What do Analysts Say About SOLV or XRAY?

    Solventum Corp. has a consensus price target of $89.25, signalling upside risk potential of 22.36%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $13.23 which suggests that it could grow by 5.53%. Given that Solventum Corp. has higher upside potential than Dentsply Sirona, Inc., analysts believe Solventum Corp. is more attractive than Dentsply Sirona, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SOLV
    Solventum Corp.
    5 6 1
    XRAY
    Dentsply Sirona, Inc.
    2 14 0
  • Is SOLV or XRAY More Risky?

    Solventum Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.012, suggesting its more volatile than the S&P 500 by 1.166%.

  • Which is a Better Dividend Stock SOLV or XRAY?

    Solventum Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.1% to investors and pays a quarterly dividend of $0.16 per share. Solventum Corp. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios SOLV or XRAY?

    Solventum Corp. quarterly revenues are $2.1B, which are larger than Dentsply Sirona, Inc. quarterly revenues of $904M. Solventum Corp.'s net income of $1.3B is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Solventum Corp.'s price-to-earnings ratio is 8.40x while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Solventum Corp. is 1.52x versus 0.69x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SOLV
    Solventum Corp.
    1.52x 8.40x $2.1B $1.3B
    XRAY
    Dentsply Sirona, Inc.
    0.69x -- $904M -$428M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock